Literature DB >> 32047089

Spontaneous regression of hepatocellular carcinoma: myth or reality?

Maria Pia Costa-Santos1, Afonso Gonçalves2, Alexandre Oliveira Ferreira3, Joana Nunes1.   

Abstract

We present a case of a 68-year-old man with chronic hepatitis C infection, with no evidence of chronic liver disease during the first years of follow-up, diagnosed with a hepatocellular carcinoma (HCC) with 40 mm (α-fetoprotein (AFP) 205 ng/mL). He underwent segmental liver resection and pathology analysis was consistent with HCC and cirrhosis in the adjacent liver. Four months after surgery, AFP raised up to 126 661 ng/mL and abdominal MRI revealed a multinodular HCC. Patient rejected treatment with sorafenib and started megestrol and an herbal medicine, soursop (Annona muricata). Six months later, AFP markedly decreased (28 ng/mL) and abdominal MRI showed decreasing size and number of lesions. At 5 years of follow-up, he has no evidence of HCC. Spontaneous regression of HCC is a rare condition and the underlying mechanism is unclear. In this case there is a temporal relation between the start of megestrol and Annona muricata and HCC regression. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cirrhosis; gastrointestinal system; hepatic cancer

Mesh:

Substances:

Year:  2020        PMID: 32047089      PMCID: PMC7035823          DOI: 10.1136/bcr-2019-233509

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  Spontaneous regression of cancer: preliminary report.

Authors:  W H COLE; T C EVERSON
Journal:  Ann Surg       Date:  1956-09       Impact factor: 12.969

2.  Spontaneous regression of pancreatic cancer with liver metastases.

Authors:  Patricia Saade Lemus; Kevin Anderson; Martin Smith; Andrea Bullock
Journal:  BMJ Case Rep       Date:  2019-05-31

3.  New adjacent Bis-tetrahydrofuran Annonaceous acetogenins from Annona muricata.

Authors:  Fang-Rong Chang; Chih-Chuang Liaw; Chih-Yuan Lin; Chi-Jung Chou; Hui-Fen Chiu; Yang-Chang Wu
Journal:  Planta Med       Date:  2003-03       Impact factor: 3.352

4.  Anti-tumor activity of Annona squamosa seeds extract containing annonaceous acetogenin compounds.

Authors:  Yong Chen; Sha-sha Xu; Jian-wei Chen; Yu Wang; Hui-qing Xu; Nai-bing Fan; Xiang Li
Journal:  J Ethnopharmacol       Date:  2012-05-17       Impact factor: 4.360

5.  Psycho-neuro-immunological treatment of hepatocellular carcinoma with major depression--a single case report.

Authors:  H Jozuka; E Jozuka; M Suzuki; S Takeuchi; Y Takatsu
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

Review 6.  Is human hepatocellular carcinoma a hormone-responsive tumor?

Authors:  Massimo Di Maio; Bruno Daniele; Sandro Pignata; Ciro Gallo; Ermelinda De Maio; Alessandro Morabito; Maria-Carmela Piccirillo; Francesco Perrone
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Spontaneous complete regression of a rectal cancer.

Authors:  S Sakamoto; K Fu; O Kobayashi; S Matsuyama; A Miyazaki; K Ogura; S Watanabe
Journal:  Endoscopy       Date:  2009-08-14       Impact factor: 10.093

8.  Functional proteomic analysis revels that the ethanol extract of Annona muricata L. induces liver cancer cell apoptosis through endoplasmic reticulum stress pathway.

Authors:  Na Liu; Hua Li Yang; Pu Wang; Yu Cheng Lu; Ying Juan Yang; Lan Wang; Shao Chin Lee
Journal:  J Ethnopharmacol       Date:  2016-05-17       Impact factor: 4.360

9.  Mitochondrial complex I inhibitors, acetogenins, induce HepG2 cell death through the induction of the complete apoptotic mitochondrial pathway.

Authors:  Nuria de Pedro; Bastien Cautain; Angeles Melguizo; Francisca Vicente; Olga Genilloud; Fernando Peláez; Jose R Tormo
Journal:  J Bioenerg Biomembr       Date:  2012-11-21       Impact factor: 2.945

10.  Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?

Authors:  Olga A Sukocheva
Journal:  World J Gastroenterol       Date:  2018-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.